Skip to main content

Table 1 Comparison of general material and biochemical indexes of each group

From: Correlational study on the levels of 25-hydroxyvitamin D and non-alcoholic fatty liver disease in type 2 diabetic patients

  T2DM with NAFLD (n = 231) Simple T2DM (n = 108) P value
Sex (male/female) 134/97 58/50 0.456
Age (years) 57.2 ± 12.2 63.2 ± 10.8 0.000
Diabetic duration (years) 8.0 (3.0–13.0) 10.0 (5.0–15.0) 0.049
BMI (kg/m2) 26.88 ± 3.28 24.69 ± 3.38 0.000
Systolic pressure(mmHg) 132 (122–145) 132 (120–152) 0.533
Diastolic pressure(mmHg) 82.8 ± 10.2 82.1 ± 10.2 0.567
Waistline(cm) 93 (88–100) 90 (85–95) 0.000
ALT(U/L) 20 (15–32) 15 (12–22) 0.000
AST(U/L) 18 (15–24) 17 (14–21) 0.019
GGT (U/L) 30.0 (21.0–44.0) 18.5 (13.0–28.0) 0.000
CR (umol/L) 57.9 (49.2–68.8) 62.8 (49.8–72.3) 0.042
UA (umol/L) 324.1 ± 91.4 304.1 ± 101.6 0.072
CysC (mg/L) 0.91 (0.80–1.05) 0.97 (0.83–1.17) 0.018
FBG (mmol/L) 7.89 (6.15–11.01) 6.86 (5.59–9.84) 0.003
TG (mmol/L) 1.90 (1.25–2.73) 1.20 (0.89–1.58) 0.000
TC (mmol/L) 4.86 ± 1.10 4.56 ± 1.21 0.023
HDL (mmol/L) 1.01 (0.86–1.20) 1.10 (0.98–1.39) 0.000
LDL (mmol/L) 2.88 ± 0.83 2.69 ± 1.04 0.072
HOMA-IR (CP) 3.90 (3.10–4.97) 2.82 (2.45–3.67) 0.000
HBA1C (%) 8.5 (7.1–9.8) 7.7 (6.8–9.5) 0.023
25-(OH) D (ng/mL) 14.80 (11.52–18.37) 16.21 (12.22–22.59) 0.009
  1. The measured data of the normal distribution was represented by mean ± SD. Measurement data for non-normal distributions were expressed as medians (interquartile intervals)
  2. Note: NAFLD Nonalcoholic fatty liver disease, T2DM Type 2 diabetes mellitus, BMI Body mass index, NFS NAFLD fibrosis score, ALT Alanine aminotransferase, AST Aspartic acid aminotransferase, GGT Glutamyltransferase, CR Creatinine, UA Uric acid, CysC Cystatin c, FBG Fasting blood glucose, TG Triglyceride, TC Total cholesterol, HDL High density lipoprotein, LDL Low density lipoprotein, Homa-IR (CP) Homeostasis model assessment for insulin resistance(C-peptide), HbA1c Glycosylatedhemoglobin, CR Creatinine, UA Uric acid, 25-(OH) D 25- hydroxyvitamin D